Filtros : "OLIGONUCLEOTÍDEOS" "PEPTÍDEOS" Removido: "Brasil" Limpar

Filtros



Refine with date range


  • Source: Pharmaceuticals. Unidades: IQ, ICB

    Subjects: PARASITOLOGIA, OLIGONUCLEOTÍDEOS, PEPTÍDEOS, VIROSES, COVID-19, VÍRUS DE DNA, VÍRUS DE RNA, MOLÉCULA, DNA VIRAL, RNA VIRAL

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      KRÜGER, Arne et al. Aptamer applications in emerging viral diseases. Pharmaceuticals, v. 14, n. 7, p. 1-19, 2021Tradução . . Disponível em: https://doi.org/10.3390/ph14070622. Acesso em: 30 set. 2024.
    • APA

      Krüger, A., Santos, A. P. de J., Sá, V. K. de, Ulrich, H., & Wrenger, C. (2021). Aptamer applications in emerging viral diseases. Pharmaceuticals, 14( 7), 1-19. doi:10.3390/ph14070622
    • NLM

      Krüger A, Santos AP de J, Sá VK de, Ulrich H, Wrenger C. Aptamer applications in emerging viral diseases [Internet]. Pharmaceuticals. 2021 ; 14( 7): 1-19.[citado 2024 set. 30 ] Available from: https://doi.org/10.3390/ph14070622
    • Vancouver

      Krüger A, Santos AP de J, Sá VK de, Ulrich H, Wrenger C. Aptamer applications in emerging viral diseases [Internet]. Pharmaceuticals. 2021 ; 14( 7): 1-19.[citado 2024 set. 30 ] Available from: https://doi.org/10.3390/ph14070622
  • Source: Frontiers in Immunology. Unidade: IQ

    Subjects: PEPTÍDEOS, OLIGONUCLEOTÍDEOS, BIOQUÍMICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TONELLI, Renata Rosito e COLLI, Walter e ALVES, Maria Júlia Manso. Selection of binding targets in parasites using phage-display and aptamer libraries in vivo and in vitro. Frontiers in Immunology, v. 3, p. 1-16, 2013Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2012.00419. Acesso em: 30 set. 2024.
    • APA

      Tonelli, R. R., Colli, W., & Alves, M. J. M. (2013). Selection of binding targets in parasites using phage-display and aptamer libraries in vivo and in vitro. Frontiers in Immunology, 3, 1-16. doi:10.3389/fimmu.2012.00419
    • NLM

      Tonelli RR, Colli W, Alves MJM. Selection of binding targets in parasites using phage-display and aptamer libraries in vivo and in vitro [Internet]. Frontiers in Immunology. 2013 ; 3 1-16.[citado 2024 set. 30 ] Available from: https://doi.org/10.3389/fimmu.2012.00419
    • Vancouver

      Tonelli RR, Colli W, Alves MJM. Selection of binding targets in parasites using phage-display and aptamer libraries in vivo and in vitro [Internet]. Frontiers in Immunology. 2013 ; 3 1-16.[citado 2024 set. 30 ] Available from: https://doi.org/10.3389/fimmu.2012.00419
  • Source: Current Cancer Drug Targets. Unidade: IQ

    Subjects: OLIGONUCLEOTÍDEOS, PEPTÍDEOS, PROTEÍNAS, BIOQUÍMICA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FARIA, M. e ULRICH, Henning. The use of synthetic oligonucleotides as protein inhibitors and anticode drugs in cancer therapy: accomplishments and limitations. Current Cancer Drug Targets, v. 2, n. 4, p. 355-368, 2002Tradução . . Acesso em: 30 set. 2024.
    • APA

      Faria, M., & Ulrich, H. (2002). The use of synthetic oligonucleotides as protein inhibitors and anticode drugs in cancer therapy: accomplishments and limitations. Current Cancer Drug Targets, 2( 4), 355-368.
    • NLM

      Faria M, Ulrich H. The use of synthetic oligonucleotides as protein inhibitors and anticode drugs in cancer therapy: accomplishments and limitations. Current Cancer Drug Targets. 2002 ; 2( 4): 355-368.[citado 2024 set. 30 ]
    • Vancouver

      Faria M, Ulrich H. The use of synthetic oligonucleotides as protein inhibitors and anticode drugs in cancer therapy: accomplishments and limitations. Current Cancer Drug Targets. 2002 ; 2( 4): 355-368.[citado 2024 set. 30 ]

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024